T1	PROC 46 60	Estudio piloto
#1	AnnotatorNotes T1	C0031928; Pilot Projects; Research Activity
T2	CHEM 92 102	etravirina
#2	AnnotatorNotes T2	C1456409; etravirine; Organic Chemical · Pharmacologic Substance
T3	CHEM 104 107	ETR
T4	CHEM 111 121	doravirina
T5	CHEM 123 126	DOR
T6	LIVB 131 138	adultos
#3	AnnotatorNotes T6	C0001675; Adult; Age Group
T7	Age 131 138	adultos
T8	DISO 139 159	infectados por VIH-1
T9	CHEM 205 208	ETR
T10	PROC 231 286	Estudio abierto, de un solo brazo, unicéntrico y piloto
T11	CHEM 318 328	etravirina
#4	AnnotatorNotes T11	C1456409; etravirine; Organic Chemical · Pharmacologic Substance
T12	CHEM 330 333	ETR
T13	CHEM 337 347	doravirina
T14	CHEM 349 352	DOR
T15	LIVB 357 364	adultos
#5	AnnotatorNotes T15	C0001675; Adult; Age Group
T16	Age 357 364	adultos
T17	DISO 365 385	infectados por VIH-1
T18	CHEM 431 434	ETR
T19	DISO 458 491	Virus de Inmunodeficiencia Humana
T20	DISO 493 496	VIH
#6	AnnotatorNotes T20	C0458074; Human immunodeficiency virus (HIV) status; Finding
T21	LIVB 526 533	Sujetos
#7	AnnotatorNotes T21	C0681850; Study Subject; Group
T22	DISO 534 557	infectados por el VIH-1
T23	Age 567 575	≥18 años
T24	LIVB 599 607	paciente
#8	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	PROC 626 640	régimen de TAR
T26	PROC 651 671	ARN plasmático VIH-1
T27	Duration 695 729	al menos las 24 semanas anteriores
T28	Date 734 745	Actualmente
T29	PROC 760 767	régimen
#9	AnnotatorNotes T29	C0012159; Diet therapy; Health Care Activity
T30	CHEM 781 784	ETR
T31	Neg_cue 786 789	sin
T32	Negated 790 797	cambios
T33	Duration 806 831	las 24 semanas anteriores
T34	PROC 841 849	genotipo
T35	CHEM 893 896	ADN
#10	AnnotatorNotes T35	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T36	PROC 1008 1016	Genotipo
T37	CHEM 1057 1060	ADN
#11	AnnotatorNotes T37	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T38	DISO 1093 1103	Mutaciones
T40	LIVB 1232 1241	lactantes
#13	AnnotatorNotes T40	C0021270; Infant; Age Group
T41	LIVB 1243 1250	mujeres
#14	AnnotatorNotes T41	C0043210; Woman; Population Group | C0242665; wife; Family Group
T42	PROC 1259 1277	prueba de embarazo
#15	AnnotatorNotes T42	C0032976; Pregnancy Tests; Diagnostic Procedure
T43	PROC 1307 1316	detección
#16	AnnotatorNotes T43	C1511790; Detection; Therapeutic or Preventive Procedure
T44	LIVB 1318 1334	mujeres fértiles
T45	PHYS 1366 1374	concebir
#17	AnnotatorNotes T45	C0009637; Conception; Organism Function
T46	Neg_cue 1377 1379	no
T47	PROC 1417 1440	métodos anticonceptivos
#18	AnnotatorNotes T47	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T48	Negated 1417 1440	métodos anticonceptivos
T49	Neg_cue 1528 1534	evitar
T50	PHYS 1538 1546	embarazo
#19	AnnotatorNotes T50	C0032961; Pregnancy; Organism Function
T51	Negated 1538 1546	embarazo
T52	Duration 1589 1598	4 semanas
T54	CHEM 1629 1640	medicamento
#20	AnnotatorNotes T54	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T55	LIVB 1664 1671	mujeres
#21	AnnotatorNotes T55	C0043210; Woman; Population Group | C0242665; wife; Family Group
T56	PROC 1731 1752	cirugía esterilizante
T57	Age 1760 1778	mayores de 50 años
T58	PHYS 1783 1792	amenorrea
T59	Duration 1812 1827	más de 12 meses
T60	PROC 1838 1845	ingreso
#22	AnnotatorNotes T60	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T61	DISO 1862 1883	Infección tuberculosa
#23	AnnotatorNotes T61	C0041296; Tuberculosis; Disease or Syndrome
T62	DISO 1906 1923	condición clínica
T63	PROC 1926 1933	terapia
#24	AnnotatorNotes T63	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T64	LIVB 1954 1966	investigador
#25	AnnotatorNotes T64	C0035173; Research Personnel; Professional or Occupational Group
T65	LIVB 1981 1990	individuo
#26	AnnotatorNotes T65	C0027361; Persons; Population Group
T66	Neg_cue 1991 1993	no
T67	Negated 1998 2022	adecuado para el estudio
T68	Neg_cue 2025 2027	no
T69	Negated 2034 2060	cumplir con los requisitos
T73	CHEM 637 640	TAR
T71	PROC 852 855	GRT
T72	PROC 1050 1053	GRT
T75	LIVB 1211 1230	Mujeres embarazadas
T74	DISO 1084 1091	DOR-DRM
#12	AnnotatorNotes T74	Doravirine (DOR) Drug-Resistance Mutation
